GlassScriptPhysician profile
Roy F Roberts
NPI 1841222759
$893.38
in general payments reported to CMS, 2019-2025
24 companies · $14.55 in 2025
The $14.55 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $16.26 · 2021: $127 · 2022: $36.34 · 2023: $187 · 2024: $169 · 2025: $14.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $109.56 | 2021 | |
| Pfizer INC. | $106.91 | 2019-2023 | |
| Allergan, INC. | $95.79 | 2019 | |
| Davol INC. | $63.38 | 2023 | Phasix Mesh |
| Portola Pharmaceuticals, LLC | $57.27 | 2019 | |
| Kerecis Limited | $55.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Acera Surgical, INC. | $48.62 | 2024 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $39.37 | 2020-2023 | Recarbrio, Zerbaxa |
| Integra Lifesciences Corporation | $38.50 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Tela Bio, INC. | $32.72 | 2019 | |
| Zimmer Biomet Holdings, INC. | $27.38 | 2023 | Ribfix Blu Advantage |
| Cerus Corporation | $24.53 | 2023 | Intercept Blood System For Platelets |
| E.R. Squibb & Sons, L.L.C. | $22.12 | 2022 | |
| Smith+Nephew, INC. | $20.90 | 2019 | |
| Abbott Laboratories | $20.36 | 2024 | I-Stat |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $19.62 | 2024 | Teg6s Hemostasis System |
| Baxter Healthcare | $19.23 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $15.53 | 2019 | |
| Prytime Medical Devices, INC. | $14.55 | 2025 | Er-Reboa Plus |
| Ethicon US, LLC | $14.44 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.92 | 2019 | |
| Sanofi Pasteur INC. | $11.76 | 2019 | |
| Applied Medical Technology INC | $11.24 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.